Progyny, Inc. reported a slight increase in revenue for the first quarter of 2026, reaching $328.5 million, up from $324.0 million in the same period last year. This 1% growth was primarily driven by a $3.0 million increase in revenue from the company's fertility benefits solution and a $1.5 million rise in revenue from its pharmacy benefits solution, Progyny Rx. The company noted that the growth was partially offset by the impact of a large client that did not renew its services for 2025, which had provided an extended transition period for certain members.

The company's gross profit for the quarter increased by 10% to $83.1 million, compared to $75.8 million in the prior year, resulting in a gross margin of 25.3%, up from 23.4%. This improvement in gross margin was attributed to efficiencies in care management services and a decrease in stock-based compensation expenses. Operating expenses also decreased, with total operating expenses falling to $47.7 million from $51.6 million, reflecting a reduction in both sales and marketing and general and administrative costs.

Progyny's net income for the first quarter of 2026 was $24.2 million, or $0.30 per share, compared to $15.1 million, or $0.18 per share, in the same quarter of 2025. The increase in net income was supported by a decrease in operating expenses and a lower effective tax rate, despite a slight decline in interest and other income. The company reported a provision for income taxes of $12.7 million, up from $11.5 million a year earlier.

In terms of operational metrics, Progyny's client base expanded to 595 employers, covering approximately 7.2 million lives as of March 31, 2026, compared to 555 employers and 6.7 million lives at the end of 2025. The company continues to focus on expanding its offerings, which now include solutions for pregnancy, postpartum, menopause, and family well-being, although these additional services have not yet significantly contributed to revenue.

Looking ahead, Progyny remains optimistic about its growth trajectory, supported by its strong client retention rates and high member satisfaction scores. The company plans to continue investing in sales and marketing to drive awareness of its fertility solutions and expand its market presence. However, it acknowledges potential risks, including competition and economic conditions, which could impact future performance.

About Progyny, Inc.

Progyny, Inc. is a benefits management company specializing in fertility, family building, and women’s health solutions in the U.S. It offers comprehensive, data-driven programs including treatment bundles, high-quality specialist networks, personalized support, and integrated pharmacy services. Its services target large employers, aiming to improve clinical outcomes, reduce costs, and attract talent through innovative, accessible fertility benefits.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.